COMMUNIQUÉS West-GlobeNewswire

Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio

01/10/2019 - 10:00

- Oerth Bio to utilize Arvinas’ PROTAC® technology to develop innovative new agricultural products to improve crop yields - John Dombrosky Announced as CEO of Oerth Bio - Transaction had been formally closed on July 15 [...]

Third-party evaluation confirms safety profile of Philips Stellarex .035″ low-dose drug-coated balloon

01/10/2019 - 10:00

October 1, 2019 Primary safety analysis of Stellarex drug-coated balloon (DCB) three-year data, comprising the largest published, pooled set of randomized controlled trial (RCT) data for a single paclitaxel-based device [...]

Integrated Cannabis’ Ganja Gold takes Delivery of Fully Automated Proprietary Pre-Roll Manufacturing Machine

01/10/2019 - 09:05

VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ” or the “ Company ”), a multi-state brand operator in California and [...]

iCAD Showcases ProFound AI™ Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest

01/10/2019 - 08:00

Company to exhibit ProFound AI for 2D and 3D Mammography in Europe NASHUA, N.H. and BUDAPEST, Hungary, Oct. 01, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative [...]

Eurobio Scientific joins the Enternext PEA PME 150 index

01/10/2019 - 08:00

Eurobio Scientific joins the Enternext PEA PME 150 index Paris, October 1st 2019 – 8:00 am Eurobio Scientific ( FR0013240934, ALERS), the leading French group in the field of in vitro medical diagnostics and life [...]

Eurobio Scientific entre dans l’indice Enternext PEA PME 150

01/10/2019 - 08:00

Eurobio Scientific entre dans l’indice Enternext PEA PME 150 Paris, le 1 er octobre 2019 – 8h00 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de [...]

Innate Pharma presents early clinical data on IPH5401 and monalizumab at the ESMO 2019 congress

01/10/2019 - 07:00

IPH5401 dose-escalation study in combination with durvalumab in advanced solid tumors, STELLAR-001, shows manageable safety profile Initiation of two expansion cohorts in non-small cell lung cancer (NSCLC) with [...]

INNATE PHARMA PRÉSENTE DES RESULTATS CLINIQUES PRELIMINAIRES SUR IPH5401 ET MONALIZUMAB AU CONGRÈS DE L’ESMO 2019

01/10/2019 - 07:00

Profil de sécurité gérable de la combinaison d’IPH5401 avec durvalumab dans l’étude en escalade de dose STELLAR-001 dans des tumeurs solides avancées Deux extensions de cohorte ont démarré : dans le cancer du poumon non [...]

IBA receives down payment for Proteus®PLUS contract in Shenzhen, China

01/10/2019 - 07:00

Seven proton therapy rooms already sold by IBA this year Louvain-la-Neuve, Belgium, 1 October, 2019 - IBA ( Ion Beam Applications SA ), the world’s leading provider of proton therapy solutions for the treatment of [...]

IBA reçoit l’acompte du contrat pour un Proteus®PLUS à Shenzhen en Chine

01/10/2019 - 07:00

IBA a déjà signé des contrats pour sept salles de protonthérapie cette année Louvain-La-Neuve, Belgique, 1 er octobre 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de [...]

FibroGen Receives One of China Pharmaceutical Industry’s Highest Awards for Clinical Innovation for Roxadustat

01/10/2019 - 02:00

SAN FRANCISCO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that roxadustat received the 2019 Dushu Lake Prize 独墅湖杯in China for “On-Market Innovative Drug with Highest Clinical Value [...]

Chimerix Announces Exclusive Global License Agreement with SymBio Pharmaceuticals for Brincidofovir

01/10/2019 - 01:30

Includes All Human Indications Excluding Prevention and Treatment of Smallpox Chimerix to Receive up to $180 Million in Potential Clinical, Regulatory, and Commercial Milestones and is Eligible for Double Digit [...]

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China

01/10/2019 - 01:00

LA JOLLA, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/10/2019 - 00:03

CAMBRIDGE, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on September 30, 2019, that were [...]

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30/09/2019 - 23:00

CAMBRIDGE, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]

Genfit: H1 2019 Results and R&D Pipeline Progression

30/09/2019 - 22:45

GENFIT: H1 2019 RESULTS AND R&D PIPELINE PROGRESSION Cash position of €282 million (€207 million at December 31, 2018) USD $155 million gross proceeds from the IPO on the Nasdaq Global Select market Signature of a [...]

GENFIT présente ses résultats financiers et l’avancée de son portefeuille de programmes de R&D au premier semestre 2019

30/09/2019 - 22:45

GENFIT présente ses résultats financiers et l’avancée de son portefeuille de programmes de R&D au premier semestre 2019 Trésorerie de Cloture de 282 M€ (contre 207 M€ au 31 décembre 2018) Levée de fonds d’un montant [...]

NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases

30/09/2019 - 22:35

-- Combined company to assume the name, Lumos Pharma, Inc. and is expected to be led by Richard J. Hawkins, current CEO of Lumos Pharma -- -- Lumos asset, LUM-201, represents first oral therapeutic candidate for [...]

Geron Announces Fast Track Designation Granted to Imetelstat for Relapsed/Refractory Myelofibrosis

30/09/2019 - 22:19

MENLO PARK, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to imetelstat for the [...]